ANDA 200149, held by Actavis Grp Ptc. Sildenafil Citrate.
As of Nov 15, 2026, ANDA 200149 (Sildenafil Citrate), held by Actavis Grp Ptc, was first approved by FDA on Feb 25, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 25, 2013 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sildenafil CitrateEQ 20MG BASE ยท tablet;oral | Sildenafil Citrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
